Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma

ClinicalTrials.gov ID: NCT00393991

Public ClinicalTrials.gov record NCT00393991. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 23, 2026, 5:16 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Parallel, Stratified, Multi-center, 12-Week Study Comparing the Safety & Efficacy of Fluticasone and Formoterol Combination (FlutiForm(tm)100/10 µg Twice Daily) in a Single Inhaler (SkyePharma HFA pMDI)With the Administration of Placebo or Fluticasone (100 µg Twice Daily) and Formoterol (10 µg Twice Daily) Alone in Adolescent and Adult Patients With Mild to Moderate Asthma

Study identification

NCT ID
NCT00393991
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
SkyePharma AG
Industry
Enrollment
475 participants

Conditions and interventions

Conditions

Interventions

  • Fluticasone propionate 100 Drug
  • Fluticasone propionate/formoterol fumarate 100/10 Drug
  • Formoterol fumarate 10 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2006
Primary completion
Mar 31, 2008
Completion
Mar 31, 2008
Last update posted
Jun 22, 2011

2006 – 2008

United States locations

U.S. sites
47
U.S. states
19
U.S. cities
45
Facility City State ZIP Site status
Research Site Pell City Alabama 35128
Research Site Scottsdale Arizona 85251
Research Site Cypress California 90630
Research Site Encinitas California 92024
Research Site Fountain Valley California 92708
Research Center Los Angeles California 90048
Research Site Mission Hills California 91345
Research Site Centennial Colorado 80112
Research Site Colorado Springs Colorado 80907
Research Site Englewood Colorado 80112
Research Site Waterbury Connecticut 06708
Research Site Aventura Florida 33180
Research Site Gainesville Florida 32610
Research Center Largo Florida 33770
Research Site Miami Florida 33176
Research Site Ocala Florida 34471
Research Site Tallahassee Florida 32308
Research Site Conyers Georgia 30012
Research Site Lawrenceville Georgia 32308
Research Site Round Lake Beach Illinois 60073
Research Site Indianapolis Indiana 46208
Research Site Bethesda Maryland 20814
Research Site Brockton Massachusetts 02301
Research Site Cherry Hill New Jersey 08003
Research Site Forked River New Jersey 08732
Research Site Asheville North Carolina 28801
Research Center Elizabeth City North Carolina 27909
Research Site Elizabeth City North Carolina 27909
Research Site Columbus Ohio 43235
Research Site Toledo Ohio 43617
Research Site Okalahoma City Oklahoma 73139
Research Site Oklahoma City Oklahoma 73104
Research Site Oklahoma City Oklahoma 73112
Research Site Eugene Oregon 97401
Research Site Lake Oswego Oregon 97035
Research Site Medford Oregon 97504
Research Site Philadelphia Pennsylvania 19115
Research Site Pittsburgh Pennsylvania 15241
Research Site Scranton Pennsylvania 18509
Research Site Austin Texas 78750
Research Site Dallas Texas 75246
Research Site El Paso Texas 79925
Research Site Houston Texas 77024
Research Site McKinney Texas 75069
Research Site Round Rock Texas 78681
Research Site San Antonio Texas 78229
Research Site Bellingham Washington 98225

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00393991, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 22, 2011 · Synced Apr 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00393991 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →